Voices
Natera Announces Webinar on PALLAS and LEADER Studies in Early Breast Cancer
Fengting Yan and Jamie McKenzie

Natera Announces Webinar on PALLAS and LEADER Studies in Early Breast Cancer

Natera shared a post on LinkedIn:

“Register today for our upcoming webinar with Fengting Yan. and Jamie McKenzie highlighting three of the twelve studies presented at the San Antonio Breast Cancer Symposium (SABCS).

Reserve your spot.

This virtual program will review and discuss findings from:

  •  PALLAS (Signatera™ Genome)1: Record-High Prognostic Performance in HR+/HER2- Early Breast Cancer
  •  Signatera™ Genome: Strong Prognostic Performance Beyond Imaging
  •  LEADER: MRD-Guided Insights in HR+ Early Breast Cancer.”

Other articles from Natera on OncoDaily. 

Breast Cancer cancer Fengting Yan Jamie McKenzie Natera OncoDaily Oncology SABCS San Antonio Breast Cancer Symposium